Tweet
ARMENIAN HIV TREATMENT TO BE REGISTERED IN GEORGIA AND KYRGYZSTAN
IHS Global Insight
December 2, 2013
by Kavita Rainova
Armenian HIV treatment Armenicum may be registered in Georgia and
Kyrgyzstan, reports theYerkramasnewspaper, citing a statement made
by the Director of the Republican Centre for Prevention of HIV/AIDS
Samvel Grigoryan. According to the report, Armenicum is a "complex
combined action drug with a wide spectrum of antiviral, antibacterial,
and immunomodulatory action".
Significance:The drug, which was developed in 1998, is currently
registered in Armenia, Russia, Ukraine and several African countries.
The potential registration of the drug in Georgia and Kyrgyzstan would
facilitate the expansion of its exports, which is in line with the
government's strategies to increase Armenia's pharmaceutical exports
(see Armenia: 19 September 2013:). According to the United Nations
Programme on HIV and AIDS, in 2012, there were around 6,600 people
living with HIV in Georgia and 8,700 in Kyrgyzstan.
From: A. Papazian
IHS Global Insight
December 2, 2013
by Kavita Rainova
Armenian HIV treatment Armenicum may be registered in Georgia and
Kyrgyzstan, reports theYerkramasnewspaper, citing a statement made
by the Director of the Republican Centre for Prevention of HIV/AIDS
Samvel Grigoryan. According to the report, Armenicum is a "complex
combined action drug with a wide spectrum of antiviral, antibacterial,
and immunomodulatory action".
Significance:The drug, which was developed in 1998, is currently
registered in Armenia, Russia, Ukraine and several African countries.
The potential registration of the drug in Georgia and Kyrgyzstan would
facilitate the expansion of its exports, which is in line with the
government's strategies to increase Armenia's pharmaceutical exports
(see Armenia: 19 September 2013:). According to the United Nations
Programme on HIV and AIDS, in 2012, there were around 6,600 people
living with HIV in Georgia and 8,700 in Kyrgyzstan.
From: A. Papazian